Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Post-market prevalence studies have found that Selective Serotonin Reuptake Inhibitor (SSRI) and Serotonin- Norepinephrine Reuptake Inhibitor (SNRI) sexual side effects occur at dramatically higher rates than initially reported in pre-market trials. Prescribing and practice conventions rest on the untested assumption that individuals who develop sexual dysfunction secondary to SSRI and SNRI antidepressant medications return fully to their pre-medication sexual functioning baseline shortly after discontinuing treatment. Most individuals probably do return to their previous level of sexual functioning, however recent case reports, consumer-provided Internet-based information, incidental research findings, and empirical evidence of persistent post SSRI sexual benefits in the premature ejaculation literature suggest that for some individuals, SSRI and SNRI-emergent sexual side effects persist indefinitely after discontinuing the medications. The literature poorly captures the full spectrum of SSRI/SNRI sexual side effects, and a lack of systematic follow-up in the sexual side effects research precludes detection of post SSRI/SNRI sexual dysfunction, leaving the formal knowledge base inadequate and even inaccurate, raising informed consent issues, and leaving clinicians vulnerable to practicing in ways that may be hurtful to patients in spite of their best efforts to inform themselves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Controlled discontinuation studies [111, 113, 114] showed that rebound may occur following SSRI discontinuation.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Severity varies according to the SSRI, paroxetine being the most likely to be associated with severe depressive and somatic symptoms, and fluoxetine being the least likely to be associated with severe depressive and somatic symptoms [5, 111].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A bulk of literature, derived from controlled trials [18, 110, 111], case reports [19], and patients' online reports [112], showed that new withdrawal symptoms may occur with any type of SSRI, but paroxetine is the most likely to be associated with new symptoms, while fluoxetine being the least associated.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In both studies [111, 113], patients treated with paroxetine had acute return of pre-treatment symptoms [10, 111, 113], while patients taking fluoxetine did not.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In one of the studies [111], patients taking paroxetine or sertraline had a sudden worsening of depressive symptoms upon drug discontinuation with a return to pre-placebo measurements following re-institution of the drug.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155 · cited 3×
“And neither unambiguously captures pleasureless orgasm or ejaculatory anhedonia; the CSFQ fails to do so by scoring decreased orgasmic intensity together with items assessing timing and frequency of orgasm, and the ASEX because the inquiry regarding changes in satisfaction from orgasm is less specific than changes in…”
InfluentialBulger, R. E. (1992) · Kennedy Institute of Ethics Journal · doi:10.1353/ken.0.0102 · Cited by 992
Professional Psychology: Research and Practice
Roberts, M. C., & Canter, K. S. (2015) · The Encyclopedia of Clinical Psychology · doi:10.1002/9781118625392.wbecp256 · Cited by 754
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542 · cited 4×
“…take medication adjunctively to psychotherapy [2], and that one in eight adult American has *Address correspondence to this author at the University Counseling Service, 3223 Westlawn S., The University of Iowa, Iowa City, Iowa 52242- 1100, USA; Tel: 319 335-7294; Fax: 319 335-7298; E-mail:…”
BackgroundInfluentialDisorders of Orgasm and Ejaculation in Men
Rowland, D., McMahon, C. G., Abdo, C., Chen, J., Jannini, E., Waldinger, M. D., & Ahn, T. Y. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01782.x · Cited by 508 · cited 1×
“Decreased orgasmic intensity or ejaculatory anhedonia are not mentioned in recent reviews of disorders of ejaculation and orgasm in men [38], or in women [39], and SSRI/SNRI-related decreased genital sensitivity or genital anesthesia, when mentioned, are reported to be uncommon [6, 14, 15].”
BackgroundMontejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505 · cited 3×
“Sexual side effects are known to occur as a result of drug treatment, but their prevalence is underestimated in the product literature, and the research literature poorly captures the quality and scope of the sexual side effects and how distressing they may be to patients.”
BackgroundMontejo, A. L., Llorca, G., Izquierdo, J. A., & Rico‐Villademoros, F. (2001) · PubMed · Cited by 460
The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.
Clayton, A. H., McGarvey, E. L., & Clavet, G. J. (1997) · PubMed · Cited by 358
Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry
Maciag, D., Simpson, K. L., Coppinger, D., Lu, Y., Wang, Y., Lin, R. C. S., & Paul, I. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300823 · Cited by 302 · cited 1×
“The patient maintained the conviction that his symptoms were a result of his past medication use, and declined the offer of a course of psychodynamic psychotherapy.”
BackgroundMeston, C. M., Hull, E., Levin, R. J., & Sipski, M. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10110.x · Cited by 267 · cited 1×
“…rates of a variety of sexual side effects; determining strategies for managing the sexual side effects: demonstrating the efficacy of one medication to serve as an antidote to the sexual dysfunction caused by another; and also on the ejaculationdelaying benefits of the various SSRIs when used as…”
Background
Research works printed but not linked: 3
- [32]32. Michael A, Mayer, C. Fluoxetine-induced anesthesia of vagina and nipples [Letter to the Editor]. Br J Psychiat 2000; 176: 984-985.
- [53]53. Montejo A L, Majadas, S. Sexual disturbances associated with antidepressant treatments. World Psychiatric Association Bulletin on Depression 2004; 9: 28.
- [55]55. Sussman N. Side effects of psychotropic medications: Importance of postmarketing surveillance. Prim Psychiat 2007; 14: 14-15.
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Post-SSRI Sexual Dysfunction: A Literature Review
Bala, A., Nguyen, H. M. T., & Hellstrom, W. J. G. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.07.002 · Cited by 167
Singh, K., Pal, R., Khan, S. A., Kumar, B., & Akhtar, M. J. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130369 · Cited by 132
Reconsidering Asexuality and Its Radical Potential
Chasin, C. D. (2013) · Feminist Studies · doi:10.1353/fem.2013.0054 · Cited by 110
American psychiatry in the new millennium: a critical appraisal
Scull, A. T. (2021) · Psychological Medicine · doi:10.1017/s0033291721001975 · Cited by 101
“Bahrick, A. S. (2008). Persistence of sexual dysfunction side effects after dis-”
BackgroundSelective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
Atmaca, M. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s185757 · Cited by 89
Ben-Sheetrit, J., Aizenberg, D., Csoka, A. B., Weizman, A., & Hermesh, H. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000300 · Cited by 55
“All the above criteria for possible case plus all the following: (6) Subject is younger than 50 years old (7) Current medical conditions reported by the subject did not include conditions associated with sexual dysfunction”
BackgroundPost-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
Giatti, S., Diviccaro, S., Panzica, G., & Melcangi, R. C. (2018) · Endocrine · doi:10.1007/s12020-018-1593-5 · Cited by 82
One hundred and twenty cases of enduring sexual dysfunction following treatment
Hogan, C., Le Noury, J., Healy, D., & Mangin, D. (2014) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-140617 · Cited by 51
“While there are long-standing reports of sexual dysfunction on isotretinoin, serotonin-reuptake inhibiting (SSRI) antidepressants and finasteride, starting from 2006 a series of descriptions of enduring sexual dysfunction following SSRIs [1–4], finasteride (Propecia) [5, 6], and isotretinoin (Accutane) [7, 8] have bee…”
BackgroundBibliotherapy as a Treatment for Depression in Primary Care
Naylor, E. V., Antonuccio, D. O., Litt, M., Johnson, G. E., Spogen, D. R., Williams, R., McCarthy, C., Lu, M. M., Fiore, D. C., & Higgins, D. L. (2010) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-010-9207-2 · Cited by 43
“There is recent evidence suggesting that sexual dysfunction may be a long-term irreversible effect for some patients after discontinuing antidepressant medications ( Bahrick, 2008 ).”
BackgroundMoncrieff, J. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000555 · Cited by 41
“Antipsychotics produce a specific state of neurological inhibition, characterised by cognitive slowing, reduced initiative and motivation and emotional restriction that is not simply attributable to their (mostly) sedative effects (Breggin, 2008; Moncrieff et al. 2009).”
BackgroundKayode, O. T., & Yakubu, M. T. (2017) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(17)60318-2 · Cited by 41
Waldinger, M. D., van Coevorden, R. S., Schweitzer, D. H., & Georgiadis, J. R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.031 · Cited by 40
“In very rare cases, the common SSRI-induced sexual side effects may persist long after SSRI discontinuation (Csoka and Shipko, 2006; Bolton et al., 2006; Csoka et al., 2008; Bahrick and Harris, 2009; Bahrick, 2008; Farnsworth and Dinsmore, 2009; Kauffman and Murdock, 2007; Kauffman, 2008).”
Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence
Healy, D. T., & Mangin, D. A. (2024) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796024000441 · Cited by 34
“It has been noted that some validated questionnaires such as the Arizona Sexual Experience Scale and the Changes in Sexual Functioning Questionnaire do not include questions about genital sensation and may not be suitable to capture the nuances of PSSD (Bahrick, 2008; Raj, 2020).”
BackgroundCitizen petition: Sexual side effects of SSRIs and SNRIs
Healy, D. (2018) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180745 · Cited by 32
“A review article published by Bahrick in the same year highlighted the signifi cance of two large placebo controlled studies into the use of SSRIs as a treatment for premature ejaculation [16].”
BackgroundA clinical guide to rare male sexual disorders
Gül, M., Fode, M. M., Ürkmez, A., Capogrosso, P., Falcone, M., Sarıkaya, S., Sokolakis, I., Morgado, A., Morozov, A., Albersen, M., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00803-5 · Cited by 31
Sexual Side Effects of Antidepressant Medications: An Informed Consent Accountability Gap
Bahrick, A. S., & Harris, M. M. (2008) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-008-9094-0 · Cited by 30
“Initiating exploration regarding the emergence of ‘‘markers’’ of medication exposure (Bahrick 2008), including decreased genital sensitivity or genital anesthesia, and decreased orgasmic intensity or pleasureless orgasm may provide further support for clarifying the contribution of medication vs.…”
BackgroundInfluentialSelf-citationGiatti, S., Diviccaro, S., Cioffi, L., & Melcangi, R. C. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101114 · Cited by 24
“In particular, sex steroids, neurotrans-mitters (i.e., serotonin and dopamine), and gut microbiota are variably interconnected with each other in PFS and PSSD.”
BackgroundInfluentialPapoutsaki, A., So, S., Kenderova, G., Shapiro, B. B., & Epstein, D. A. (2021) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3479564 · Cited by 21
“However, discontinuation of antidepressants (and all psychiatric drugs) may be clinically indicated in a number of scenarios, including: (1) reported intolerable side effects, such as nausea, fatigue, sexual side effects, weight gain or emotional numbing [8, 34, 37, 43]; (2) lack of efficacy in treating the targeted c…”
BackgroundPersistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies
Simonsen, A. L., Danborg, P. B., & Gøtzsche, P. C. (2016) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-160668 · Cited by 20
The pathophysiology of Post SSRI Sexual Dysfunction – Lessons from a case study
Klaas, S., Siva, J. B., Bak, M., Govers, M., & Schreiber, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114166 · Cited by 19
Sidi, H., Asmidar, D., Hod, R., & Ng, C. G. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02256.x · Cited by 18
Farnsworth, K. D., & Dinsmore, W. W. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008402 · Cited by 17
Effects of paroxetine treatment and its withdrawal on neurosteroidogenesis
Giatti, S., Diviccaro, S., Cioffi, L., Falvo, E., Caruso, D., & Melcangi, R. C. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105364 · Cited by 16
Relabeling the Medications We Call Antidepressants
Antonuccio, D. O., & Healy, D. T. (2012) · Scientifica · doi:10.6064/2012/965908 · Cited by 16
“However, the real-world outcomes with antidepressants may actually be much worse than those in the placebo-controlled trials. e STAR∗D [12] study, a large (N = 4.041 depressed patients) and well-funded (35 million dollars from NIMH) study, was designed to mimic the real word.”
BackgroundInfluentialPost-SSRI Sexual Dysfunction: Preclinical to Clinical. Is It Fact or Fiction?
Coşkuner, E. R., Çulha, M. G., Özkan, B., & Orhan, E. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.11.004 · Cited by 14
Patacchini, A., & Cosci, F. (2021) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-200074 · Cited by 12
“Even though such manifestations are assumed to be transient and commonly disappearing at drug discontinuation, in some cases they persist long after treatment discontinuation [3].”
Patacchini, A., & Cosci, F. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001154 · Cited by 10
Understanding the Experiences of People with Post-SSRI Sexual Dysfunction
Rice, E. E., Kleinplatz, P. J., Richardson, H. M., DiCaita, H., D’souza, K., Charest, M., & Rosen, L. A. (2025) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2025.2495959 · Cited by 10
Stinson, R. D., Liu, W. M., Westefeld, J. S., Paik, A., Altmaier, E. M., Bahrick, A. S., & Ali, S. R. (2013) · doi:10.17077/etd.g7ynuvfm · Cited by 7
“As discussed by Bahrick (2006, 2008), two of the most common PSSD symptoms, genital anesthesia and orgasmic anhedonia, cannot be accounted for by either depression or DSM-IV-TR sexual dysfunctions.”
BackgroundInfluentialSelf-citationPaudel, P., Choi, J. S., Prajapati, R., Seong, S. H., Park, S. E., Kang, W.-C., Ryu, J.-H., & Jung, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115859 · Cited by 6
A Way to Increase the Sensitivity and Specificity of the Hamilton Depression and Anxiety Scales
Günver, M. G., Senocak, M. S., İlhan, R., Aktas, H., Kilic, S. C., Öksüz, Ö., Esmeray, M. T., Çetin, H. L., & Arıkan, M. K. (2021) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2021.21386 · Cited by 5
“16 As for loss of appetite, the appetite hormones are sensitive to acute and chronic stress, and thus, appetite may be increased or decreased in patients with anxiety.”
BackgroundМорозова, М. А., Сафарова, Т. П., Глускина, Л. Я., Penchul, N. A., Касимова, Л. Н., Заярная, И. И., Бойчевская, Ю. О., Ширяев, О. Ю., Резников, М. К., Бухановская, О. А., et al. (2024) · Современная терапия психических расстройств · Cited by 4
A Systemic Approach to Sex Therapy
Hertlein, K. M., & Nelson, M. (2017) · Wiley eBooks · doi:10.1002/9781118510384.ch13 · Cited by 3
HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
Karabulut, İ. Y., Gökçay, H., & Belli, H. (2021) · Psychiatria Danubina · doi:10.24869/psyd.2021.187 · Cited by 3
“Selective serotonin reuptake inhibitors (SSRIs) can be used in the treatment of many psychiatric disorders such as major depressive disorder, generalized anxiety disorder, panic disorder (Bahrick & Audrey 2008).”
BackgroundSexual Functioning in Females with OCD: A Comparative Cross-sectional Study
Jaiswal, N., Tripathi, A., Gupta, B., & Singh, S. (2025) · Journal of Psychosexual Health · doi:10.1177/26318318251324316 · Cited by 2
Effects of doxepin on physiology of reproduction in adult male rats
Shariati, M., Mokhtari, M., Amiri, F., & Kazemi, M. R. (2010) · فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران · Cited by 2
Antonuccio, D. O., & Higgins, D. J. (2010)
Ketamine: use in psychiatry, its pharmacology and treatment following intoxication
Oruch, R., Pryme, I. F., Fasmer, O. B., & Lund, A. (2021) · Minerva Psychiatry · doi:10.23736/s2724-6612.21.02068-9
(2010) · Elsevier eBooks · doi:10.1016/b978-1-84334-543-5.50011-6
Data-driven neural mass modelling
Sofia, L. (2019) · UPCommons institutional repository (Universitat Politècnica de Catalunya) · doi:10.5821/dissertation-2117-131745
The Ethics of Informed Consent in Sexual Medicine
Watter, D. N. (2024) · Current Sexual Health Reports · doi:10.1007/s11930-024-00391-4
“…accepted that an adequate informed consent consists of a five-step are aware of the sexual side-effects of medications such as the SSRIs, but much of this information comes from reports contained in mainstream media as opposed to a thoughtful and thorough discussion with the prescriber [2–4].”
Doutani, M. K., Rahi, R., Nawaz, S., Naila, & Qadir, A. (2025) · Journal of Health Wellness and Community Research · doi:10.61919/1n13yr28
“Importantly, these neurochemical changes may persist beyond treatment discontinuation, explaining the phenomenon of post-SSRI sexual dysfunction (PSSD), which has been increasingly recognized in the literature and regulatory reports (32).”
The Effect of Stressor Controllability on Social Hedonic Preference in Laboratory Rats
Daniels, S. (2020) · The Atrium (University of Guelph)
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/saimsara343e1f7e
Mulvehill, S. (2026) · Current Sexual Health Reports · doi:10.1007/s11930-026-00428-w
Metadata
- Authors
- Bahrick, A. S.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Bahrick, Audrey S.
- Venue
- The Open Psychology Journal
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-05-05
- Volume
- 1
- Issue
- 1
- Pages
- 42-50
- ISSN
- 1874-3501 (ISSN-L)
- OpenAlex
- W2127932170
- Semantic Scholar
- a6c2453868b92651a0ebdb91efabaf6f05ccba07
- Cited by
- 41
- References
- 61
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2021: 7 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Open Psychology Journal (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- sexual dysfunction, antidepressant side effects, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, premature ejaculation, informed consent
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.